Works matching IS 03065251 AND DT 2014 AND VI 78 AND IP 5


Results: 28
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Effect of UGT1A1, UGT1A3, DIO1 and DI02 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.

    Published in:
    British Journal of Clinical Pharmacology, 2014, v. 78, n. 5, p. 1067, doi. 10.1111/bcp.12437
    By:
    • Santoro, Ana B.;
    • Vargens, Daniela D.;
    • Barros Filho, Mateus de Camargo;
    • Bulzico, Daniel A.;
    • Kowalski, Luiz Paulo;
    • Meirelles, Ricardo M. R.;
    • Paula, Daniela P.;
    • Neves, Ronaldo R. S.;
    • Pessoa, Cencita N.;
    • Struchine, Claudio J.;
    • Suarez‐Kurtz, Guilherme
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28